To further explore the mechanism of U0126 and BAY11-7082 in the treatment of EMs rats, the expression of key proteins MEK1/2, ERK1/2, and NF-κBp65 in the signaling pathway was determined at the protein level. The gene discussed is MAP2K1; the disease is eosinophilia-myalgia syndrome.